Efficacy and Safety of Rociletinib Versus Chemotherapy in Patients With EGFR-Mutated NSCLC: The Results of TIGER-3, a Phase 3 Randomized Study by Yang, James Chih-Hsin, MD, PhD, Reckamp, Karen L., MD, Kim, Young-Chul, MD, PhD, Novello, Silvia, MD, PhD, Smit, Egbert F., MD, PhD, Lee, Jong-Seok, MD, PhD, Su, Wu-Chou, MD, Akerley, Wallace L., MD, Blakely, Collin M., MD, PhD, Groen, Harry J.M., MD, PhD, Bazhenova, Lyudmila, MD, Carcereny Costa, Enric, MD, Chiari, Rita, MD, PhD, Hsia, Te-Chun, MD, PhD, Golsorkhi, Tony, MD, Despain, Darrin, MStat, Shih, Danny, BA, Popat, Sanjay, BSc, MBBS, FRCP, PhD, Wakelee, Heather, MD

Get full text